<DOC>
	<DOCNO>NCT02076880</DOCNO>
	<brief_summary>Sleeve gastrectomy restrictive procedure base removal large part gastric fundus . According recent randomized study , weight loss resolution diabetes comparable obtain gastric by-pass ( 79.7 % versus 80.3 % ) , low morbidity . The mechanism involve rapid resolution diabetes sleeve gastrectomy remain poorly understood , specific study patient type 2 diabetic obese available . An increase post- absorptive level Glucagon-like Peptide 1 ( GLP-1 ) , Peptide YY ( PYY ) insulin report , non-diabetic subject mostly . The important caloric restriction early postoperative period indeed improve hepatic insulin resistance , regardless weight loss . Specific metabolic hormonal effect surgical procedure excluded.The aim study explore early late metabolic effect sleeve gastrectomy severely obese patient non-insulin-treated type 2 diabetes . We also evaluate insulin sensitivity , insulin secretion incretin effect . We include 14 obese patient type 2 diabetes , consider eligible bariatric surgery accord HAS criterion , whose diabetes treatment involve metformin , sulfonylurea glinides . They randomize 1-week caloric restriction period caloric restriction , immediately surgery . Test meal dosages blood glucose , insulin , C-peptide , adiponectin , leptin , GLP-1 , PYY ghrelin perform caloric restriction , 1 week , 3 month , 6 month 12 month surgery .</brief_summary>
	<brief_title>SLEEVEDIAB To Explore Early Late Metabolic Effects Sleeve Gastrectomy Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>write informed consent Age 1865 year ( inclusive ) Men woman receive effective contraception , postmenopausal sterile type 2 diabetes treat drug oral antidiabetic agent metformin , sulfonylurea glinides Body mass index 35 kg / mÂ² eligible bariatric surgery accord HAS criterion Treatment diabetes GLP1 analogue , DPPIV ( dipeptidylpeptidase IV ) insulin Treatment drug modify glucose homeostasis : glucocorticoid , anorexigens , antihistaminics , psychotropic drug especially serotonergic antidepressant ( except occasional use hypnotic anxiolytic ) , atropine , laxative , thyroid hormone ( exception substitution dose ensure stable euthyroid baseline ) , beta blocker , diuretic Pregnancy , intention pregnant , breastfeed . Inability understand nature aim study communicate investigator High probability non compliance protocol Simultaneous participation another trial No affiliation French social security Loss personal capacity result state protection Deprivation liberty judicial administrative decision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Obesity</keyword>
	<keyword>Sleeve gastrectomy</keyword>
	<keyword>Insulin</keyword>
	<keyword>GLP-1</keyword>
</DOC>